Eur Rev Med Pharmacol Sci 2019; 23 (3): 903-905
DOI: 10.26355/eurrev_201902_16970

The radiation oncologist point of view on “Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation”

M.A. Signor, G. Parisi, G. Chiaulon, M. Trovo

Department of Radiation Oncology, Azienda Sanitaria Universitaria Integrata UD, Udine, Italy. marco.signor@asuiud.sanita.fvg.it

Free PDF Download

To cite this article

M.A. Signor, G. Parisi, G. Chiaulon, M. Trovo
The radiation oncologist point of view on “Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation”

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 3
Pages: 903-905
DOI: 10.26355/eurrev_201902_16970

Keywords Related articles:

  1. Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation
  2. Comment on “Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation”
  3. Excess of weight: is it a modifiable predictive and prognostic factor in locally advanced rectal cancer?
  4. Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells. Point of view from pharmacogenetics field
  5. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view